Market Leads & Opportunities

Bouygues to build Covid-19 vaccine factory in Scotland


Bouygues Energies & Services is designing and building a Covid-19 vaccine manufacturing facility in Scotland.It has been picked by specialist vaccine company Valneva for the plant, which will be built in Livingston.Clinical trials for Valneva’s vaccine began in mid-December and the UK government has pre-ordered millions of doses.The manufacturing facility is formed of:A new multi-vaccine facility (MVF), adjacent to an existing vaccine facility. It will house two manufacturing streams and testing laboratories to produce Valneva’s inactivated whole-virus Covid-19 vaccine. All areas where the live virus will be handled will be designed to meet the requirements of ACDP containment level 3 as agreed with the Health & Safety Executive.A new warehouse facility that will consist of temperature-controlled storage areas along with goods in and off-loading bays;An energy centre that will shelter all essential plant services to serve the main manufacturing facility and associated labs;Shared hub facilities that will comprise the main site entrance, offices and employee’s welfare areas as well as the staff car park and the access road for the delivery.Bouygues Energies & Services, as the main design and build partner, will be responsible for the industrial park development. Engineering, construction, commissioning and validation of the new facilities will be delivered on a phased basis. Master-planning of the industrial park began in July 2020 and the production of vaccines will begin in the first half of this year.# COVID-19